[36] The lawsuit focused specifically on how PBM formulary decisions for insulin the most politically charged drug category after years of price-rationing scandals had systematically disadvantaged lower-list-price products in favor of products that generated larger rebates
He's like, dude, of course
The supplemented mice gained significantly less weight, had lower fat mass, and showed increased energy expenditure compared to controls
and more recently, metabolic-dysfunction associated steatohepatitis (MASH)
This is a brand new breakthrough in the treatment of obesity worldwide
In the TRIUMPH-1 trial, participants on the highest dose (12 mg) lost an average of 70.3 lbs (28.3%) over 80 weeks, with 65.3% achieving a BMI below 30